[HTML][HTML] Gadolinium and nephrogenic systemic fibrosis

T Grobner, FC Prischl - Kidney international, 2007 - Elsevier
Nephrogenic systemic fibrosis (NSF) is characterized by red skin areas or plaques that over
several weeks successively develop to painful thickened skin with a 'woody'texture …

Skin problems in chronic kidney disease

DRJ Kuypers - Nature Reviews Nephrology, 2009 - nature.com
Skin disorders associated with chronic kidney disease (CKD) can markedly affect a patient's
quality of life and can negatively impact their mental and physical health. Uremic pruritus …

Gadolinium–a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

T Grobner - Nephrology Dialysis Transplantation, 2006 - academic.oup.com
Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and
nephrogenic systemic fibrosis? | Nephrology Dialysis Transplantation | Oxford Academic Skip to …

Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis

WA High, RA Ayers, J Chandler, G Zito… - Journal of the American …, 2007 - Elsevier
BACKGROUND: Nephrogenic systemic fibrosis (NSF) is a disease of unknown etiology that
affects a subset of patients with renal insufficiency. Recent publications suggested an …

Case-control study of gadodiamide-related nephrogenic systemic fibrosis

P Marckmann, L Skov, K Rossen… - Nephrology Dialysis …, 2007 - academic.oup.com
Background. Nephrogenic systemic fibrosis may be caused by gadolinium (Gd)-containing
magnetic resonance imaging contrast agents. Most reported cases were associated with …

Gadolinium-induced fibrosis

DJ Todd, J Kay - Annual review of medicine, 2016 - annualreviews.org
Gadolinium-based contrast agents (GBCAs), once believed to be safe for patients with renal
disease, have been strongly associated with nephrogenic systemic fibrosis (NSF), a severe …

Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue

CD Wiginton, B Kelly, A Oto, M Jesse… - American Journal of …, 2008 - Am Roentgen Ray Soc
OBJECTIVE. The objective of our study was to retrospectively review one institution's cases
of nephrogenic systemic fibrosis (NSF), evaluate possible associated factors, determine the …

Scleroderma-like fibrosing disorders

F Boin, LK Hummers - Rheumatic Disease Clinics of North America, 2008 - Elsevier
Many conditions presenting with clinical hard skin and tissue fibrosis can be confused with
systemic sclerosis (scleroderma). These disorders have very diverse etiologies and often an …

Nephrogenic systemic fibrosis and gadolinium-based contrast agents

AK Abu-Alfa - Advances in chronic kidney disease, 2011 - Elsevier
The strong association between nephrogenic systemic fibrosis (NSF) and exposure to
gadolinium-based contrast agents (GBCAs) has greatly affected the care of patients with …

Involvement of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: an update

JM Idée, M Port, A Dencausse… - Radiologic …, 2009 - radiologic.theclinics.com
Gadolinium chelates (GCs) are widely used to enhance the diagnostic efficacy of MR
imaging for the detection and characterization of lesions and for the evaluation of perfusion …